Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Decoding the substrate supply to human neuronal nitric oxide synthase.
Characterization of Microcirculation in Multiple Sclerosis Lesions by Dynamic Texture Parameter Analysis (DTPA).
Multiple sclerosis: Gene-vitamin D interactions likely to influence pathogenesis and risk of relapse in multiple sclerosis.
Magnetic resonance spectroscopic findings of chronic lesions in two subtypes of multiple sclerosis: primary progressive versus relapsing remitting.
Tamoxifen promotes differentiation of oligodendrocyte progenitors in vitro.
High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.
Myelinating Cultures: An In Vitro Tool to Identify Demyelinating and Axopathic Autoantibodies.
Assessment of plasma brain-derived neurotrophic factor (BDNF), activity-dependent neurotrophin protein (ADNP) and vasoactive intestinal peptide (VIP) concentrations in treatment-naïve humans with multiple sclerosis.
Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice.
Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in manitoba, Canada.
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Occurrence of Autoimmune Diseases Related to the Vaccine against Yellow Fever.
Treatment with Anti-EGF Ab Ameliorates Experimental Autoimmune Encephalomyelitis via Induction of Neurogenesis and Oligodendrogenesis.
A randomized, controlled, single-blind, 6-month pilot study to evaluate the efficacy of MS-Line!: a cognitive rehabilitation programme for patients with multiple sclerosis.
[Immunotherapies for multiple sclerosis : Review and update.]
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Clinical and MRI phenotype of children with MOG antibodies.
The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis.
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
Tolerogenic vaccines for Multiple sclerosis.
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
Cyclic AMP and Polyamines Overcome Inhibition by Myelin-Associated Glycoprotein through eIF5A-Mediated Increases in p35 Expression and Activation of Cdk5.
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosis.
Multiple sclerosis and cancer: When two wrongs make a right?

Pages